Christopher Twitty serves as Chief Scientific Officer at Skye Bioscience, Inc., where they oversee executive responsibilities. Since joining the company, Christopher Twitty has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 6, 2026 involved receiving (via award) 150,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 6, 2026 | SKYE | $0 | Award | 150,000 | $N/A | Discretionary |
Christopher Twitty currently holds 150,000 shares of Skye Bioscience, Inc. (SKYE), valued at approximately $0. This represents their equity stake as Chief Scientific Officer.
Based on SEC Form 4 filings, Christopher Twitty has been a net neutral trader of SKYE stock. They have purchased $0 and sold $0 worth of shares.
Christopher Twitty's most recent insider trade was on Feb 6, 2026, when they sold 150,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted